Pierre Fabre Group

[Made in France] 🇫🇷 “Stick to what you know, and everything will go well.” This is the mantra we took away from our conversation with Benjamin Robert, our dedicated 800m runner 🏃♂️ Benjamin, part of the #SporTeamPierreFabre, shared invaluable insights on sports, support, and well-being. He highlights the crucial balance in life and athletics and emphasizes the power of supportive networks for long-term success. Let’s rally behind our incredible athlete and cheer him for this summer’s big competition 💪 #NewWaysToCare #PierreFabre #Sport #Competition #Running

Pierre Fabre Laboratories are thrilled to announce that the European Commission (EC) has granted marketing authorization (MA) for their symptomatic treatment of overactive bladder syndrome in adults 🙌.   "We are delighted with this development, which will allow European patients to benefit from a new therapeutic option for overactive bladder syndrome and further strengthen our expertise of over 40 years in urology. This decision confirms Pierre Fabre Laboratories' commitment to offering patients new therapies for the management of chronic debilitating diseases." - Eric Ducournau, CEO of Pierre Fabre Laboratories.   The EC's decision follows the favorable opinion issued in April by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).  This approval is grounded in positive data from two pivotal, multicenter, double-blind, randomized phase 3 studies involving patients with overactive bladder symptoms.     At Pierre Fabre Laboratories, we are committed to pioneering advancements across diverse health fields, delivering comprehensive solutions, and prioritizing exceptional patient care 💙. 👉 Learn more on Pierre Fabre Pharmaceutical Care #PierreFabre #NewWaysToCare #Innovation #Urology HQ--07-24-2400003

[Inside The Labs] Discover the heart of the Fondation Pierre Fabre’s mission with Solenne Barbe, our Programs Director. 💙 With over two and a half years of dedication, Solenne ensures that our initiatives, from training healthcare professionals to improving access to healthcare, create meaningful changes for vulnerable populations. "What motivates me every day is seeing the impact of our interventions on beneficiaries in the countries we work in, as well as the quality of the people we collaborate with daily." #NewWaysToCare #FondationPierreFabre #PierreFabre #Innovation

[Numbers that Matter] Taking care of patient’s and consumers health and wellbeing is at the core of #PierreFabre Laboratories’ mission. To fulfill it, we rely on research in our main care areas: Medical care & Dermo-cosmetics. In 2023 alone, we allocated over 190M € towards R&D to develop new innovative treatments in oncology, branching out into innovative areas of oncology, dermatology, and rare diseases. Additionally, our focus on dermo-cosmetics ensures that we provide advanced skincare solutions that meet the highest standards of efficacy and safety. ”Offering effective and safe products to assist consumers and patients in living a better life. That's the mission of a life-changing scientific cosmetics” F. Ennabli. #NewWaysToCare #Research #Dermatology #MedicalCare #Dermocosmetics 

This year in Munich we are proud to announce our participation in two major events 🙌 !   Pierre Fabre Laboratories are Gold Sponsors of the upcoming #ESMOGI2024 congress from June 26th to 29th, we are also sponsoring the 14th “European Post-Chicago Melanoma/Skin Cancer meeting” on June 27th and 28th.   📆 Mark your calendars: ESMO GI: 👉 Sponsored Satellite Symposium on June 26th at 18:15 CEST “Tackling real-life challenges in BRAFV600E-mutant metastatic colorectal cancer” 📍 Meet us at booth n°03 Post-Chicago: 👉 Sponsored Satellite Symposium on June 28th at 10:00 CEST "Tailoring treatments in BRAFV600-mutant metastatic melanoma: One size does not fit all“ 📍 Meet us at booth n°M_02   Let's connect, learn, and advance care together at #ESMOGI24 and #POSTCHICAGO24 At Pierre Fabre Laboratories, our current oncology expertise covers colorectal, breast, lung cancers, melanoma and hematology. Through our innovative approaches, we are committed to making a positive impact on global health, in line with our purpose : “Every time we take care of a single person, we make the world better ”   #PierreFabre #Oncology #NewWaysToCare #melanoma #ColorectalCancer #EPCM2024

[Inno 360°] Lucile Garidou, active ingredient manager at A-Derma, shares the story behind the development of the Night Peeling Serum, a cutting-edge skincare product for Acne-prone skin. This collaborative work, centered around natural and plant-based ingredients, exemplifies Pierre Fabre Laboratories commitment to innovation and R&D, ensuring care for all skin types. #PierreFabre #NewWaysToCare #Innovation #Skincare #Research #ADerma #Acne

Breaking news : Pierre Fabre Laboratories have been awarded the prestigious “#PrixGalien International” for their allogeneic T-cell therapy 🏆 which was competing in the "Best Product for a Rare/Orphan Disease" category. The same therapy also received the “Prix Galien” Italy Award in the "Advanced Therapy Medicinal Product" category 💪. This breakthrough monotherapy is dedicated to the treatment of patients with post-transplant lymphoproliferative disorder positive for Epstein-Barr virus. The latter is a very rare and potentially lethal hematological malignancy. This type of lymphoma might arise in transplant patients with compromised immune response due to immunosuppression, allowing the EB virus to proliferate and develop a lymphoproliferative disease As a symbol of scientific rigor, excellence, and innovation, the “Prix Galien International” awards remarkable recent health innovations available to the public, following an evaluation done by an independent committee of experts. The Galien prize exists in fifteen countries, its reputation and influence have made it the most prestigious distinction in the field of medical innovation.  This award highlights the innovation capacity of Pierre Fabre Laboratories in oncology and rare diseases, two of our priority areas of development in medical care alongside dermatology. We are grateful to the teams who have made this achievement possible at Pierre Fabre and Atara Biotherapeutics, the biotech company from which we have acquired the global development and commercial rights for this breakthrough T-cell therapy 🙌🙌 “Every time we take care for a single person, we make the whole world better." This our corporate purpose and this Galien Prize for a rare disease therapy gives it a very special resonance! We will continue to innovate and strive to make a meaningful impact in the field of oncology, rare diseases and dermatology improving lives and driving forward the future of healthcare 💙. The Galien Foundation Pier Luigi Canonico Eric Ducournau Nuria Perez Cullell Jean-Luc Lowinski Clémentine Sergeant Théodore Leondaridis Cristina Hesse Charles-Henri Bodin Mariaelena Soffientini Werner Suzzi #PierreFabre #NewWaysToCare #Innovation #Oncology #Healthcare #Galien #RareDiseases #Immunotherapy

[Made in France] "Believe in your dreams" is what we learned from our meeting with Maïlys Piazzalunga, our climbing athlete, at the Avène thermal center. 🧗🏼♀️ Maïlys joined other members of the #SporTeamPierreFabre to share a convivial moment and answer some of our questions about sports, support, and well-being. "Sometimes it seems a bit cliché as an expression, but if there is something that drives you deep inside, whether it's sports or anything else, you really have to believe in your abilities, trust yourself, and believe in your dreams" - Maïlys Piazzalunga #NewWaysToCare #PierreFabre #Competition #Avène #Sport #Climbing

[Inno 360°] At Pierre Fabre Laboratories, we know that digital tools can be major assets in medical training. 💻🥼 That’s why, for nearly 10 years, we’ve been integrating all our dermatology expertise into the Youdermoscopy app, which allows dermatologists to train in dermatoscopy, to recognise different skin conditions. Dermatoscopy is an essential technique to monitor skin diseases. Mainly used to evaluate pigmented skin lesions, it facilitates the diagnosis of melanoma. “We have harnessed all our dermatological expertise in this app, which provides dermatologists with an intuitive way to practice identifying skin conditions using images captured with a dermatoscope. We believe that e-health is an engaging way to augment training approaches to deliver the most effective patient care." Nuria Perez Cullell, Head of the Medical and Patient Consumer Department. #Dermatology #Dermatoscopy #Youdermatoscopy

Our Medical and patient/consumer relations Director, Nuria Perez Cullell, was present at the Common Good Summit 🌟 It was an opportunity to highlight the growing integration of data and #ArtificialIntelligence (AI) in the pharmaceutical industry to push boundaries further 🚀. Pierre Fabre Laboratories stand out with their dual focus on dermo-cosmetics and pharmaceuticals. 👨⚕️Collaborating with healthcare professionals, we address health conditions comprehensively: from prevention, through treatment, to post-treatment follow-up. Our tailored solutions aim to enhance patients' quality of life throughout their care journey. 👨💻We believe the future of healthcare is more personalized and targeted. #AI enables us to analyze increasing amounts of data, covering a wide range of factors, to provide the most suitable care for each patient. Our collaboration with the Filière Intelligence Artificielle & Cancers (FIAC) exemplifies this vision. This pioneering public-private partnership encourages the merging of #data between industry and public bodies and transforms #data into tangible innovations for oncology patients. Leveraging machine learning and #data visualization, we aim to understand care sequences and predict therapeutic outcomes, ensuring patients receive the best possible care 💙. 👉 More here: https://lnkd.in/e-3sbcnS Les Echos Le Parisien Evénements La Dépêche du Midi #PierreFabre #NewWaysToCare #CommonGoodSummit #Healthcare #Patient #Oncology #Innovation